The rising here interest in potent weight management has spurred considerable research into novel treatments. Lately , Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated encouraging results in patient trials, suggesting potential for substantial weight loss . Therefore, several individuals ar